Company / R&D per Share
ABEONA THERAPEUTICS INC. R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.59
FY2025
5-year range
$0.31 / $6.58
FY2021-FY2025
Trend
-49.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D per Share has declined for 3 consecutive years, from $6.58 in FY2022 to $0.59 in FY2025.
Based on SEC 10-K filings.
0.59 in FY2025 with a 5-year CAGR of +0.2%.
Declined from $1.63 to $0.59 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -55.3%
- 5-Year CAGR
- +0.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- ABEONA THERAPEUTICS INC.'s r&d per share has declined for 3 consecutive years.
- In FY2025, r&d per share decreased 49.9% year-over-year.
- Peak r&d per share was recorded in FY2022.
- Lowest r&d per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -2.42 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.59 | -49.9% |
| FY2024 | $1.17 | -28.3% |
| FY2023 | $1.63 | -75.1% |
| FY2022 | $6.58 | +1997.8% |
| FY2021 | $0.31 | -46.0% |
| FY2020 | $0.58 | +63.9% |
| FY2019 | $0.35 | -57.1% |
| FY2018 | $0.83 | +95.6% |
| FY2017 | $0.42 | +147.0% |
| FY2016 | $0.17 | -0.3% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026